Philips gains FDA nod for cardiac X-ray system:
This article was originally published in Clinica
Executive Summary
Philips Medical Systems has gained US FDA 510(k) clearance to sell its Integris Allura Flat Detector catheterisation lab system, which is claimed to improve small heart vessel imaging while both reducing X-ray exposure to the patient and procedure times. The system comprises a next-generation flat detector, X-ray sensor that captures and converts more X-rays into visible light and features smaller digital pixels, which result in sharper coronary vessel images, said the firm.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continue, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.